|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 2 March 2004
doi: 10.1242/jcs.01001
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232-6840, USA
* Author for correspondence: (e-mail: al.reynolds{at}mcmail.vanderbilt.edu)
Accepted 18 November 2003
Epidermal growth factor receptor (EGFR) signals to p120ctn (p120), implying a role for EGFR in modulating cell-cell adhesion in epithelial tissues. p120 controls cadherin turnover, and may have other roles that modulate cadherin adhesiveness. To clarify the role for EGFR and other tyrosine kinases in regulating p120 function, we have generated and characterized a new phosphospecific antibody to p120 Y228, as well as a novel siRNA-based reconstitution system for analyzing roles of individual p120 phosphorylation events. In A431 cells, epidermal growth factor induced striking p120 phosphorylation at Y228. Y228-phosphorylated p120 localized to adherens junctions and lamellipodia, and was significantly enhanced in cells around the colony periphery. A screen of carcinoma cell lines revealed that some contain unusually high steady state levels of Y228 phosphorylation, suggesting that disregulated kinase activity in tumors may affect adhesion by constitutive cross talk to cadherin complexes. Despite these observations, mutation of Y228 and other prominent Src-associated p120 phosphorylation sites did not noticeably reduce the ability of E-cadherin to assemble junctions and induce compaction of cultured cells. Although A431 cells display significant activation of both EGFR and Src kinases, our data suggest that these account for only a fraction of the steady state activity that targets p120 Y228, and that Src family kinases are not necessary intermediates for epidermal growth factor-induced signaling to p120 Y228.
Key words: p120 catenin, Cadherin, Src, EGFR, Adherens junction, Adhesion
This article has been cited by other articles:
![]() |
P. R. Molli, L. Adam, and R. Kumar Therapeutic IMC-C225 Antibody Inhibits Breast Cancer Cell Invasiveness via Vav2-Dependent Activation of RhoA GTPase Clin. Cancer Res., October 1, 2008; 14(19): 6161 - 6170. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Ogden, L. E. Wroblewski, C. Weydig, J. Romero-Gallo, D. P. O'Brien, D. A. Israel, U. S. Krishna, B. Fingleton, A. B. Reynolds, S. Wessler, et al. p120 and Kaiso Regulate Helicobacter pylori-induced Expression of Matrix Metalloproteinase-7 Mol. Biol. Cell, October 1, 2008; 19(10): 4110 - 4121. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ezaki, R.-J. Guo, H. Li, A. B. Reynolds, and J. P. Lynch The homeodomain transcription factors Cdx1 and Cdx2 induce E-cadherin adhesion activity by reducing beta- and p120-catenin tyrosine phosphorylation Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G54 - G65. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Chernyavsky, J. Arredondo, Y. Kitajima, M. Sato-Nagai, and S. A. Grando Desmoglein Versus Non-desmoglein Signaling in Pemphigus Acantholysis: CHARACTERIZATION OF NOVEL SIGNALING PATHWAYS DOWNSTREAM OF PEMPHIGUS VULGARIS ANTIGENS J. Biol. Chem., May 4, 2007; 282(18): 13804 - 13812. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Castano, G. Solanas, D. Casagolda, I. Raurell, P. Villagrasa, X. R. Bustelo, A. Garcia de Herreros, and M. Dunach Specific Phosphorylation of p120-Catenin Regulatory Domain Differently Modulates Its Binding to RhoA Mol. Cell. Biol., March 1, 2007; 27(5): 1745 - 1757. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bose, H. Molina, A. S. Patterson, J. K. Bitok, B. Periaswamy, J. S. Bader, A. Pandey, and P. A. Cole Phosphoproteomic analysis of Her2/neu signaling and inhibition PNAS, June 27, 2006; 103(26): 9773 - 9778. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Koop, M. F. B. G. Gebbink, T. E. Sweeney, M.-J. Mathy, H. F. G. Heijnen, J. A. E. Spaan, E. E. Voest, E. VanBavel, and S. L. M. Peters Impaired flow-induced dilation in mesenteric resistance arteries from receptor protein tyrosine phosphatase-{micro}-deficient mice Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1218 - H1223. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Moran, D. H. Hunt, S. H. Javid, M. Redston, A. M. Carothers, and M. M. Bertagnolli Apc Deficiency Is Associated with Increased Egfr Activity in the Intestinal Enterocytes and Adenomas of C57BL/6J-Min/+ Mice J. Biol. Chem., October 8, 2004; 279(41): 43261 - 43272. [Abstract] [Full Text] [PDF] |
||||